ARCHIVES

ASCO, FDA Website To Help Demystify Expanded Access

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

Cancer Congress Program Developed

June 27, 1980

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

Final Issue of 1980

December 19, 1980